STU3 Candidate

This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0322.xml

Raw XML (canonical form)

Dispense for Dilantin Oral Suspension (NDC code) - completed (id = "meddisp0322")

<MedicationDispense xmlns="http://hl7.org/fhir">
    <id value="meddisp0322"/>
    <text><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: meddisp0322</p><p><b>status</b>: completed</p><p><b>medication</b>: Dilantin 125mg/5ml Oral Suspension <span>(Details : {http://hl7.org/fhir/sid/ndc code '0071-2214-20' = '0071-2214-20', given as
           'Dilantin 125mg/5ml Oral Suspension'})</span></p><p><b>patient</b>: <a>Donald Duck</a></p><p><b>dispenser</b>: <a>Rob van den Berk</a></p><p><b>authorizingPrescription</b>: <a>MedicationRequest/medrx0312</a></p><p><b>type</b>: partial Fill <span>(Details : {http://hl7.org/fhir/ValueSet/v3-ActPharmacySupplyType code 'PF' = 'PF', given
           as 'partial Fill'})</span></p><p><b>quantity</b>: 360 ml<span> (Details: UCUM code ml = 'ml')</span></p><p><b>daysSupply</b>: 30 Day<span> (Details: UCUM code d = 'd')</span></p><p><b>whenPrepared</b>: 16/01/2015 7:13:00 AM</p><p><b>whenHandedOver</b>: 18/01/2015 7:13:00 AM</p><p><b>dosageInstruction</b>: </p></div></text><status value="completed"/>
   <medicationCodeableConcept>
       <coding>
           <system value="http://hl7.org/fhir/sid/ndc"/>
           <code value="0071-2214-20"/>
           <display value="Dilantin 125mg/5ml Oral Suspension"/>
       </coding>
   </medicationCodeableConcept>
    <patient>
        <reference value="Patient/pat1"/>
        <display value="Donald Duck"/>
    </patient>
    <dispenser>
        <reference value="Practitioner/f006"/>
        <display value="Rob van den Berk"/>
    </dispenser>
    <authorizingPrescription>
        <reference value="MedicationRequest/medrx0312"/>
    </authorizingPrescription>
    <type>
        <coding>
            <system value="http://hl7.org/fhir/ValueSet/v3-ActPharmacySupplyType"/>
            <code value="PF"/>
            <display value="partial Fill"/>
        </coding>
    </type>
    <quantity>
        <value value="360"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="ml"/>
    </quantity>
    <daysSupply>
        <value value="30"/>
        <unit value="Day"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="d"/>
    </daysSupply>
    <whenPrepared value="2015-01-16T07:13:00+05:00"/>
    <whenHandedOver value="2015-01-18T07:13:00+05:00"/>
    <dosageInstruction>
        <sequence value="1"/>
        <text value="100mg (4ml) three times daily"/>
        <timing>
            <repeat>
                <frequency value="3"/>
                <period value="1"/>
                <periodUnit value="d"/>
            </repeat>
        </timing>
        <route>
            <coding>
                <system value="http://snomed.info/sct"/>
                <code value="26643006"/>
                <display value="Oral Route (qualifier value)"/>
            </coding>
        </route>
        <doseQuantity>
            <value value="4"/>
            <unit value="ml"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="ml"/>
        </doseQuantity>
    </dosageInstruction> 
</MedicationDispense>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.